Skip to main content
. 2019 Sep 6;64(6):955–964. doi: 10.1007/s00484-019-01785-z

Table 4.

Distribution of the scores of subjects’ pain intensity questionnaire before, after treatment, and after 1 month after treatment (I, II, III stage), with respect to groups of subjects

Group I (n = 32) Group II (n = 30) Group III (n = 30) p value
A (SD), score
Over the past month
  Stage I 5.88 (1.66) 6.33 (2.34) 5.67 (2.51) F = 0.729, p = 0.485
  Stage II 4.44 (1.93) 4.57 (2.47) 5.27 (2.75) χ2 = 2.774, p = 0.25
  Stage III 3.63 (2.04)a 4.38 (2.44) 5.13 (2.66)a F = 3.09, ap = 0.044
During daytime
  Stage I 5.97 (1.91) 6.27 (2.10) 4.93 (2.52) χ2 = 5.024, p = 0.081
  Stage II 4.03 (2.10) 4.40 (2.34) 4.57 (2.74) F = 0.406, p = 0.668
  Stage III 3.25 (2.08) 4.48 (2.61) 4.57 (2.64) χ2 = 4.934, p = 0.085
During night time
  Stage I 4.16 (2.60) 4.37 (3.18) 3.37 (3.58) χ2 = 2.939, p = 0.23
  Stage II 2.81 (2.16) 3.07 (2.57) 3.13 (3.69) χ2 = 0.953, p = 0.621
  Stage III 2.34 (1.98) 2.55 (2.38) 3.0 (3.73) χ2 = 0.6, p = 0.741
When moving
  Stage I 6.69 (2.07) 7.17 (2.10) 5.73 (2.48) χ2 = 5.553, p = 0.062
  Stage II 4.81 (2.15) 5.33 (2.59) 5.40 (2.63) χ2 = 1.172, p = 0.556
  Stage III 4.25 (2.53) 4.72 (2.52) 5.20 (2.46) χ2 = 2.194, p = 0.334
When changing position
  Stage I 6.69 (2.49) 6.90 (2.35) 6.03 (2.48) χ2 = 2.371, p = 0.306
  Stage II 4.66 (2.07) 5.0 (2.69) 5.90 (2.85) F = 1.948, p = 0.149
  Stage III 4.06 (2.50)a 4.55 (2.60) 5.77 (2.89)a F = 3.325, p = 0.485, ap = 0.047
At rest
  Stage I 3.47 (2.36) 3.40 (2.43) 3.03 (3.10) χ2 = 1.299, p = 0.522
  Stage II 2.28 (2.28) 2.77 (2.34) 2.87 (3.32) χ2 = 0.967, p = 0.617
  Stage III 1.50 (1.74) 1.83 (1.58) 2.93 (3.27) χ2 = 2.319, p = 0.314

Group I, provided with bath procedures; group II, provided with mud procedures; group III, control; A, average; SD, standard deviation; F, by Fisher test; χ2, by Kruskal–Wallis test.

a,bp < 0.05